Dongmei Zhao

34PUBLICATIONS
12CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsMedical infection agents (incl. prions)PharmacogenomicsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 16, 2026
Discovery of ZSL-M028: A Potent, Selective and Orally Available Quinazoline-Based PLK4 Inhibitor Targeting TRIM37-Amplified Neuroblastoma.

|Jul 14, 2026
Rational Design and Discovery of CZx-243: A Highly Stable and Orally Bioavailable Triazole CYP51 Inhibitor for the Treatment of Invasive Fungal Infections.

|May 20, 2026
Lead Optimization of Xanthone Derivatives as Hepatitis B Virus cccDNA Reducers: Design, Synthesis, and Bioevaluation.

|Oct 23, 2025
Design, synthesis, and biological evaluation of 2-phenylthiazole CYP51 inhibitors.

Kejian Li, Guoqi Zhang, Wenzhan Hao

|Oct 13, 2025
Design, synthesis, and antifungal activity of novel amide imidazole CYP51 inhibitors with aromatic fused ring hydrophobic side chains.

Zixuan Gao, Wenzhan Hao, Jinming Liu

|Oct 08, 2025
Design, synthesis, and biological evaluation of indazole-based PLK4 inhibitors.

Cunzheng Fan, Nian Liu, Ningyuan Hu

Pageof 6

Frequent Collaborators

10 joint publications

Maosheng Cheng

7 joint publications

Nian Liu

3 joint publications

Hanxun Wang

2 joint publications

Yongxiang Liu